Insider · CIK 0001951490
David P. Ryan
Files at CGEM (Cullinan Therapeutics, Inc.). First filing -, latest -.
David P. Ryan files SEC Form 4 as director at CGEM (Cullinan Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David P. Ryan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | CGEM Cullinan Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +38,513 | $0.00 | $0 | 38,513 | Jun 16, 2025 |
Questions about David P. Ryan
Answered from the filings on this page, as of the latest one.
Is David P. Ryan buying or selling?
David P. Ryan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David P. Ryan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David P. Ryan has 0.
Where does David P. Ryan file Form 4?
David P. Ryan has filed Form 4 at CGEM (Cullinan Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.